ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.175,21
1,01%
S&P 500
5.180,74
1,03%
Dow Jones
38.852,27
0,46%
Euro vs US Dollar
1,0757
-0,10%
Bitcoin
63.543,81
0,60%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. AstraZeneca PLC (AZN)

  7. AstraZeneca PLC (AZN) News

AZN

AstraZeneca (AZN)

AstraZeneca PLC
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:AZN
DatumZeitQuelleÜberschriftSymbolFirma
01/11/202320h15AllPennyStocks.comBiotech Shares Soar After AstraZeneca Stake & Research CollaborationNYSE:AZNAstraZeneca PLC
28/06/202323h28Edgar (US Regulatory)Annual Report of Employee Stock Plans (11-k)NYSE:AZNAstraZeneca PLC
02/06/202318h13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
01/06/202318h08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
01/06/202312h37Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
26/05/202312h19Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
22/05/202312h54Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
17/05/202312h44Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
09/05/202312h57Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
09/05/202312h47Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
02/05/202315h12Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
27/04/202320h19Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
27/04/202320h11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
27/04/202312h45Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
26/04/202318h18Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
11/04/202312h42Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
03/04/202313h52Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
27/03/202312h29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
22/03/202312h29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
22/03/202312h04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
13/03/202321h38Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NYSE:AZNAstraZeneca PLC
03/03/202322h34Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
02/03/202322h55Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NYSE:AZNAstraZeneca PLC
01/03/202317h53Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
01/03/202312h27Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NYSE:AZNAstraZeneca PLC
28/02/202316h19Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NYSE:AZNAstraZeneca PLC
21/02/202322h59Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
21/02/202314h25Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
13/02/202315h14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
09/02/202314h49Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
 Showing the most relevant articles for your search:NYSE:AZN

Kürzlich von Ihnen besucht

NASDAQ
AMZN
Amazon.com
CCOM
US30
US 30
FX
EURJPY
Euro vs Yen
TG
BAYN
Bayer
NYSE
DIS
Walt Disney
NYSE
XOM
Exxon Mobil
NYSE
MRK
Merck
AMEX
XLE
Energy Select Sector SPDR
FX
EURUSD
Euro vs US Dollar
NASDAQ
AAPL
Apple
NASDAQ
TSLA
Tesla
USOTC
BASFY
BASF (QX)
TG
TUI1
Tui
CCOM
US500
US 500
TG
ALV
Allianz
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten